Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-03

Clinical Trial Update: A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

This document describes a Phase 2 clinical trial evaluating the efficacy, safety, pharmacokinetics and pharmacodynamics of SHR-1819 injection in seasonal allerg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SHR-1819

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: RECRUITING